Trial Profile
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs MK 2048/vicriviroc (Primary) ; MK 2048; Vicriviroc
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2018 Results published in the Clinical Infectious Diseases
- 04 Oct 2018 Results published in the Clinical Infectious Diseases
- 15 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.